Bioniche Life Sciences is a research-based biopharm company that discovers, develops, manufactures and markets proprietary products for human and animal health markets. The company operates three global business divisions: human health, animal health and food safety. BNC’s Urocidin™ is a formulation of Mycobacterial Cell Wall-DNA Complex (MCC) for the treatment of bladder cancer. A phase 3 clinical program is underway, in partnership with Endo Pharmaceuticals Inc. For further information, visit the company’s Web site at www.bioniche.com

EBD Group’s Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco for this important event.

Let us hear your thoughts below: